NEW: We've expanded Stock Detail, Screener, and Maps with new data

Stock Detail, Screener:
3, 5, 10-Year Performance
EV/EBITDA, EV/Sales
Dividend Growth (1, 3, 5 Years)
EPS & Sales Growth (3 Years)

Maps:
All from Screener plus:
ROA, ROE, ROIC
Quick & Current Ratios
LT Debt and Debt to Equity Ratios
Gross, Operating, and Net Margins

Last Close
Jun 30 04:00PM ET
19.54
Dollar change
-0.13
Percentage change
-0.66
%
Index- P/E- EPS (ttm)-6.53 Insider Own2.17% Shs Outstand171.50M Perf Week3.39%
Market Cap3.31B Forward P/E16.38 EPS next Y1.19 Insider Trans0.00% Shs Float165.81M Perf Month5.85%
Enterprise Value3.79B PEG- EPS next Q0.23 Inst Own114.16% Short Float6.13% Perf Quarter15.14%
Income-1124.20M P/S1.32 EPS this Y39.39% Inst Trans-0.52% Short Ratio3.73 Perf Half Y3.11%
Sales2.50B P/B1.10 EPS next Y17.26% ROA-18.70% Short Interest10.17M Perf YTD1.30%
Book/sh17.70 P/C3.07 EPS next 5Y23.84% ROE-31.33% 52W High23.00 -15.04% Perf Year18.35%
Cash/sh6.36 P/FCF12.37 EPS past 3/5Y- - ROIC-25.29% 52W Low14.22 37.41% Perf 3Y-47.60%
Dividend Est.- EV/EBITDA14.81 Sales past 3/5Y0.02% -1.82% Gross Margin54.26% Volatility2.35% 2.81% Perf 5Y-8.09%
Dividend TTM- EV/Sales1.52 EPS Y/Y TTM-854.21% Oper. Margin5.49% ATR (14)0.57 Perf 10Y-
Dividend Ex-Date- Quick Ratio1.82 Sales Y/Y TTM-2.30% Profit Margin-44.90% RSI (14)62.34 Recom2.64
Dividend Gr. 3/5Y- - Current Ratio2.12 EPS Q/Q-23.81% SMA203.21% Beta1.01 Target Price19.04
Payout- Debt/Eq0.51 Sales Q/Q-1.07% SMA509.89% Rel Volume0.74 Prev Close19.67
Employees12300 LT Debt/Eq0.46 EarningsMay 01 AMC SMA2003.46% Avg Volume2.72M Price19.54
IPOSep 18, 2019 Option/ShortYes / Yes EPS/Sales Surpr.18.46% 1.74% Trades Volume2,020,525 Change-0.66%
Date Action Analyst Rating Change Price Target Change
May-27-25Upgrade Robert W. Baird Neutral → Outperform $23
Dec-04-24Initiated Mizuho Underperform $20
Oct-31-24Upgrade Leerink Partners Underperform → Market Perform $16 → $23
Oct-08-24Initiated Wells Fargo Equal Weight $20
Aug-08-24Downgrade JP Morgan Overweight → Neutral $23 → $16
Apr-26-24Downgrade Morgan Stanley Overweight → Equal-Weight $33 → $21
Feb-26-24Initiated Leerink Partners Underperform $19
Feb-09-24Downgrade Jefferies Buy → Hold $30 → $23
Feb-08-24Downgrade William Blair Outperform → Mkt Perform
Jan-05-24Initiated UBS Neutral $26
Jun-26-25 11:40AM
04:21AM
Jun-19-25 08:17AM
Jun-18-25 07:52AM
Jun-10-25 12:00PM
11:40AM Loading…
11:40AM
Jun-09-25 12:00AM
May-28-25 02:42PM
May-22-25 04:15PM
May-21-25 04:53PM
May-16-25 11:31AM
06:43AM
May-15-25 11:23AM
May-13-25 09:16AM
May-09-25 05:00AM
07:10AM Loading…
May-06-25 07:10AM
May-02-25 08:45AM
03:19AM
May-01-25 09:05PM
06:30PM
05:45PM
04:48PM
04:05PM
Apr-30-25 07:16AM
Apr-29-25 01:19PM
Apr-28-25 06:13PM
06:10AM
05:01AM
Apr-24-25 10:01AM
05:02AM
06:02AM Loading…
Apr-19-25 06:02AM
Apr-16-25 05:05AM
Apr-10-25 07:16AM
Apr-08-25 04:15PM
Mar-31-25 11:13AM
09:51AM
Mar-24-25 09:00AM
Mar-23-25 08:06PM
Mar-10-25 05:03AM
Mar-07-25 11:30AM
Mar-04-25 04:01AM
Feb-25-25 04:10PM
Feb-19-25 09:00AM
Feb-10-25 08:01AM
Feb-06-25 11:49AM
02:17AM
Feb-05-25 06:30PM
05:35PM
05:21PM
04:31PM
04:05PM
Feb-04-25 04:10PM
07:08AM
Feb-03-25 09:30AM
Jan-29-25 10:00AM
Jan-27-25 04:10PM
Jan-14-25 04:10PM
Jan-08-25 04:05PM
Jan-07-25 04:10PM
Jan-02-25 09:40AM
Dec-10-24 07:00AM
Nov-28-24 09:30AM
Nov-20-24 04:10PM
Nov-19-24 04:10PM
Nov-06-24 07:39AM
Nov-04-24 09:15AM
Oct-31-24 10:50AM
03:19AM
Oct-30-24 07:30PM
05:50PM
04:45PM
04:10PM
Oct-23-24 10:01AM
09:00AM
Oct-07-24 04:10PM
Sep-24-24 09:30AM
09:30AM
Aug-27-24 04:10PM
Aug-26-24 06:00AM
Aug-15-24 09:00AM
12:03AM
Aug-13-24 11:43PM
Aug-12-24 09:15AM
Aug-08-24 11:13AM
10:31AM
Aug-07-24 06:30PM
05:35PM
04:29PM
04:10PM
07:32AM
Aug-06-24 09:15AM
Jul-31-24 10:01AM
Jul-15-24 04:10PM
Jul-12-24 04:45PM
Jun-21-24 02:42AM
Jun-07-24 09:15AM
Jun-03-24 04:10PM
May-31-24 11:31AM
May-21-24 04:10PM
May-02-24 11:04AM
Envista Holdings Corp. engages in the manufacturing and marketing of dental products, diagnostics, treatment, and trading. It operates through the Specialty Products and Technologies, and Equipment and Consumables segments. The Specialty Products and Technologies segment develops, manufactures and markets dental implant systems, dental prosthetics and associated treatment software and technologies, as well as orthodontic bracket systems, aligners and lab products. The Equipment and Consumables segments develops, manufactures and markets dental equipment and supplies used in dental offices, including digital imaging systems, software and other visualization/magnification systems, handpieces and associated consumables, treatment units and other dental practice equipment, endodontic systems and related consumables, restorative materials and instruments, rotary burs, impression materials, bonding agents and cements and infection prevention products. It offers dental consumables, equipment, and services to dental professionals. The company was founded in 2018, and is headquartered in Brea, CA.
Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total SEC Form 4
Keel Paul AChief Executive OfficerAug 13 '24Buy16.8730,000506,100402,605Aug 14 04:40 PM
Hammes Eric D.Chief Financial OfficerAug 12 '24Buy16.3324,532400,60824,532Aug 13 06:01 PM
Conley EricFormer OfficerAug 06 '24Proposed Sale16.0012,798204,831Aug 06 04:59 PM